PhytoMedical Technologies, Inc. (PYTO.OB-$1.06), an early stage research-based biopharmaceutical company, is focused on the development and commercialization of innovative plant derived pharmaceutical and nutraceutical compounds. Currently, the Company is involved in the identification, research, and development of plant-derived compounds for diabetes and cachexia (which is characterized by dramatic weight loss, particularly in AIDS or end-stage Cancer patients).
MORE TECHNICAL PROBLEMS
GOOGLE SUCKS!!!!!!!!
No comments:
Post a Comment